Impact of thrombophilic genetic factors on pulmonary embolism: Early onset and recurrent incidences

Lung

Volumn 186, Issue 1, 2008, Pages 27-36

  Ivanov, Petar ^a   Komsa Penkova, Regina ^a   Kovacheva, Katia ^a   Ivanov, Yavor ^a   Stoyanova, Angelina ^a   Ivanov, Ivan ^a   Pavlov, Plamen ^a   Glogovska, Pavlina ^a   Nojarov, Venzislav ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

Inherited thrombophilic genetic factors; Pulmonary embolism; Risk of early and recurrent onset

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DIHYDROFOLATE REDUCTASE; FIBRINOGEN RECEPTOR; METHYLENTETRAHYDROFOLATE REDUCTASE; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; DNA DETERMINATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITY; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; THROMBOEMBOLISM;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; ODDS RATIO; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; PROTHROMBIN; PULMONARY EMBOLISM; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 38949104443     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-007-9061-7     Document Type: Article

References (45)

1. Goldhaber SZ (1994) Epidemiology of pulmonary embolism and deep vein thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds) Hemostasis and Thrombosis, 3rd ed. Edinburgh, UK: Churchill Livingstone, pp 1327-1333
2. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 151:933-938
3. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group (2003) British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 58:470-484
4. Craig W, De Staercke C (2002) The relationship between FV Leiden and pulmonary embolism. Respir Res 3:8
5. Turkstra F, Karemaker R, Kuijer PM, Prins MH, Buller HR (1999) Is the presence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thromb Haemost 81:345-348
6. Margaglione M, Brancaccio V, Delucia D, Martinelli I, Ciampa A, Grandone E, Di Mino G (2000) Inherited thrombophilic risk factors and venous thromboembolism. Chest 118(5):1405-1411
7. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 341:801-806
8. Friedline J, Ahmad E, Garcia D, Blue D, Ceniza N, Mattson JC, Crisan D (2001) Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes. Arch Pathol Lab Med 125:105-111
9. Nizankowska-Mogilnicka E, Adamek L, Grzanka P, Domagala TB, Sanak M, Krzanowski M, Szczeklik A (2003) Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J 21:25-30
10. Simioni P, Prandoni P, Lensing AWA, Scudeller A, Sardella C, Prins MH, Villalta S, Dazzi F, Girolami A (1997) The risk of recurrent venous thromboembolism in patients with an Arg506 Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 336:399-403
11. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the three untranslated regions of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698
12. Margaglione M, D'Andrea G, Colaizzo D, Cappucci G, del Popolo A, Brancaccio V, Ciampa A, Grandone E, Di Minno G (1999) Coexistence of factor V Leiden and factor II A20210 mutations and recurrent thromboembolism. Thromb Haemost 82:1583-1587
13. Fermo I, D'Angelo SV, Paroni R, Mazzola G, Calori G, D'Angelo A (1995) Prevalence of moderate hyperhomocysteinemia in patients with early onset venous and arterial occlusive disease. Ann Intern Med 123:747-753
14. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR (2007) No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med 167(5):497-501
15. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D'Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19(4):1142-1147
16. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K (1997) PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of myocardial infarction, stroke and venous thrombosis. Lancet 349:385-358
17. Renner W, Winkler M, Hoffmann C, Koppel H, Seinost G, Brodmann M, Pilger E (2001) The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis. Int Angiol 20(2):148-151
18. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) (1989) Current Protocols in Molecular Biology vol 2. One Source 4 Media, Clemmons, NC, pp 11.5.1
19. Mullis KB, Faloona FA (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Meth Enzymol 155:335-350
20. Blanck A, Glück B, Wartbichler R, Bender S, Pöll M, Brandl A (1995) Activity of restriction enzymes in a PCR mix. Biochemica, vol 2. Boehringer Mannheim GmbH, p 14
21. Moller J, Ahola L, Abrahamsson L (2002) Evaluation of the DPC IMMULITE 2000 assay for total homocysteine in plasma. Scand J Clin Lab Invest 62:369-374
22. Bland JM, Altman DG (2000) Statistics Notes. The odds ratio. BMJ 320:1468
23. Heit JA (2003) Risk factors for venous thromboembolism. Clin Chest Med 24:1-12
24. Perry SL, Ortel TL (2003) Clinical and laboratory evaluation of thrombophilia. Clin Chest Med 24:153-170
25. Ogzulgen IK, NN Eim N Akar K Demirel M Kitapci (2002) The role of thrombophilic risk factors in the severity of pulmonary embolism. Eur Respir J 19:705-711
26. Van der Meer FJM, Koster T, Vandenbroucke JP, Briet E, Rosendaal FR (1997) The Leiden Thrombophilia Study (LETS). Thromb Haemost 78:631-635
27. Boyanovski B, Russeva M, Ganev V, Penev M, Baleva M (2001) Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis. Blood Coagul Fibrinolysis 12(8):639-642
28. Isotalo PA, Donnely JG (2000) Prevalence of methylenetetrahydrofolatereductase mutations in patients with venous thrombosis. Mol Diagn 5:59-66
29. Perrier A (2000) Deep vein thrombosis and pulmonary embolism. Chest 118(5):1234-1236
30. Bounameaux H (2000) Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 356:182-183
31. De Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H (2000) Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 110:125-129
32. Bauer K (2001) The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 135:367-373
33. Manten B, Westendorp RGJ, Koster T, Reistma PH, Rosendaal FR (1996) Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: A focus on the factor V Leiden mutation. Thromb Haemost 76:510-513
34. Ho KW, Hankey GJ, Quinlan DJ, Eikelboom JW (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia. Arch Intern Med 166:729-736
35. Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Minar E, Lechner K, Kyrle PA (1997) The risk of recurrent venous thromboembolism in patients with and without factorV Leiden. Thromb Haemost 77:624-628
36. Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H (1999) The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. Thromb Haemost 81:684-689
37. Mansilha A, Arau F, Severo M, Sampaio S, Toledo T, Albuquerque R (2005) Genetic polymorphisms and risk of recurrent deep venous.thrombosis in young people: prospective cohort study. Eur J Vasc Endovasc Surg 30:545-549
38. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U (1999) Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 19:511-518
39. Ehrenforth S, von Depka Prondsinski M, Aygoren-Pursun E, Nowak-Gottl U, Scharrer I, Ganser A (1999) Study of the prothrombin gene 20210 GA variant in FV: Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism. Arterioscler Thromb Vasc Biol 19:276-280
40. Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti ML, Bignell M, Mannucci PM (1997) A common mutation in the methylenetetrahydrofolatereductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol 17:1662-1666
41. Bertina R, Koeleman B, Koster T (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
42. Ridker P, Glynn RJ, Miletich J,Goldhaber Z, Stampfer M, Hennekens C (1997) Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 126:528-531
43. Stein P, Hull R, Kayali F, Ghali W, Alshab A, Olson R (2004) Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med 164:2260-2265
44. Folsom AR, Cushman M, Tsai MY, Aleksic N, Heckbert SR, Boland LL, Tsai AW, Yanez ND, Rosamond WD (2002) A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood 99(8):2720-2725
45. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386-1389